Could Coca-Cola Amatil Ltd be the Comeback King of 2015?

The best time to buy a stock is when it is out-of-favour.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The financial year (FY) just ended was a very disappointing period for investors in Coca-Cola Amatil Ltd (ASX: CCL). For the year ending 30 June 2014, the beverage maker's share price fell just over 25%; in contrast the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) gained 12%.

What's more, as we near the conclusion of the first month of the current financial year things aren't looking any better. CCA's share price is down a further 2.4%, meanwhile the index continues to rally having gained 3.3% so far this month!

Much of the fall in CCA's share price can be attributable to the price war being waged between the major supermarket chains owned by Woolworths Limited (ASX: WOW) and Wesfarmers Ltd (ASX: WES), and also competitive pricing pressure being applied by CCA's biggest rival Schweppes.

While some of these pressures are largely outside of CCA's control, the company is still busy refining its business model to improve its future, for example through the revival of its beer business. Ultimately it will take time for CCA to adjust to industry changes, however there is one BIG reason why CCA could be the 'Comeback King' of FY 2015 – valuation.

According to consensus data provided by Morningstar, CCA is forecast to earn 63.7 cents per share (cps) in FY 2015 and pay a dividend totalling 51 cps. Based on these forecasts, the stock is trading on a price-to-earnings ratio of 14.5 and a partly franked dividend yield of 5.5%.

Highlighting the appeal of CCA on valuation grounds is the comparison with the average PE and yield of the S&P/ASX100 Industrials (ex-Financials) of 17.6x and 4.4% respectively. It also suggests there could be scope for a re-rating of this quality blue-chip stock in the coming year.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »